★ WIDE MOAT STOCKS COMPARISON ★

Checking

Stock Comparison

Elekta AB (publ) vs Stevanato Group S.p.A.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Elekta AB (publ)

EKTA B · NASDAQ Stockholm

Market cap (USD)$2.1B
Gross margin (TTM)37.4%
Operating margin (TTM)5.3%
Net margin (TTM)-3.1%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountrySE
Data as of2026-06-03
Moat score
70/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Elekta AB (publ)'s moat claims, evidence, and risks.

View EKTA B analysis

Stevanato Group S.p.A.

STVN · New York Stock Exchange

Market cap (USD)$4.9B
Gross margin (TTM)29%
Operating margin (TTM)16.6%
Net margin (TTM)11.8%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryIT
Data as of2026-05-27
Moat score
61/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Stevanato Group S.p.A.'s moat claims, evidence, and risks.

View STVN analysis

Comparison highlights

  • Moat score gap: Elekta AB (publ) leads (70 / 100 vs 61 / 100 for Stevanato Group S.p.A.).
  • Segment focus: Elekta AB (publ) has 2 segments (55.8% in Solutions); Stevanato Group S.p.A. has 3 segments (47% in High-Value Solutions).
  • Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
  • Moat breadth: Elekta AB (publ) has 7 moat types across 3 domains; Stevanato Group S.p.A. has 8 across 3.

Primary market context

Elekta AB (publ)

Solutions

Market

Radiotherapy treatment delivery systems and oncology software solutions (linacs, MR-Linacs, stereotactic radiosurgery, treatment planning & oncology information systems)

Geography

Global

Customer

Hospitals, cancer centers, and clinics (often via public/central procurement)

Role

Medical device OEM + software/platform provider

Revenue share

55.8%

Stevanato Group S.p.A.

High-Value Solutions

Market

High-value primary packaging and integrated solutions for injectable drugs

Geography

Global

Customer

Pharmaceutical, biotechnology, and life sciences companies; fill-finish CMOs

Role

Primary packaging/component manufacturer (ready-to-use), plus supporting services

Revenue share

47%

Side-by-side metrics

Elekta AB (publ)
Stevanato Group S.p.A.
Ticker / Exchange
EKTA B - NASDAQ Stockholm
STVN - New York Stock Exchange
Market cap (USD)
$2.1B
$4.9B
Gross margin (TTM)
37.4%
29%
Operating margin (TTM)
5.3%
16.6%
Net margin (TTM)
-3.1%
11.8%
Sector
Healthcare
Healthcare
Industry
Medical - Instruments & Supplies
Medical - Instruments & Supplies
HQ country
SE
IT
Primary segment
Solutions
High-Value Solutions
Market structure
Oligopoly
Oligopoly
Market share
40%-44% (reported)
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Strong
Moat score
70 / 100
61 / 100
Moat domains
Supply, Legal, Demand
Demand, Supply, Network
Last update
2026-06-03
2026-05-27

Moat coverage

Shared moat types

Capex Knowhow ScaleService Field Network

Elekta AB (publ) strengths

Compliance AdvantageProcurement InertiaData Workflow LockinInstalled Base ConsumablesSwitching Costs General

Stevanato Group S.p.A. strengths

Design In QualificationDe Facto StandardBrand TrustLong Term ContractsOperational ExcellenceScope Economies

Segment mix

Elekta AB (publ) segments

Full profile >

Solutions

Oligopoly

55.8%

Service

Quasi-Monopoly

44.2%

Stevanato Group S.p.A. segments

Full profile >

High-Value Solutions

Oligopoly

47%

Other Containment and Delivery Solutions

Competitive

44%

Engineering

Competitive

9%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.